STAAR Surgical Reports Fourth Quarter and Full Year 2021 Results

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today reported financial results for the fourth quarter and fiscal year ended December 31, 2021. Fourth Quarter 2021 Overview Net Sales of $59.0 Million Up 28% from the Prior Year Quarter ICL Sales of $53.0 Million Up 33% from the Prior Year Quarter ICL Units Up 36% from the Prior Year Quarter Gross Margin a